Weight loss drugs like Ozempic and Mounjaro may influence brain health and memory
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Researchers from the University of Gothenburg and the University of Copenhagen reviewed evidence on obesity and type 2 diabetes medications like semaglutide and tirzepatide, noting links to reduced dementia risk in patient records and animal learning benefits. However, clinical trials like Novo Nordisk's EVOKE and EVOKE+ showed semaglutide did not slow early Alzheimer's disease progression.
Continue in the app — vote & join in ➔Source: ScienceDaily · via ahirlevel.hu